Solihat Nur Alifia, . (2023) AKURASI DIAGNOSTIK DENGAN MENGGUNAKAN BIOMARKER METILASI DNA DALAM DETEKSI DINI KANKER PARU: TINJAUAN SISTEMATIS. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.
![[img]](http://repository.upnvj.ac.id/style/images/fileicons/text.png) |
Text
ABSTRAK.pdf Download (15kB) |
|
Text
AWAL.pdf Download (464kB) |
|
Text
BAB 1.pdf Download (86kB) |
|
Text
BAB 2.pdf Restricted to Repository UPNVJ Only Download (341kB) |
|
Text
BAB 3.pdf Restricted to Repository UPNVJ Only Download (136kB) |
|
Text
BAB 4.pdf Restricted to Repository UPNVJ Only Download (820kB) |
|
Text
BAB 5.pdf Download (71kB) |
|
Text
DAFTAR PUSTAKA.pdf Download (97kB) |
|
Text
RIWAYAT HIDUP.pdf Restricted to Repository UPNVJ Only Download (78kB) |
|
Text
LAMPIRAN.pdf Restricted to Repository UPNVJ Only Download (685kB) |
|
Text
HASIL PLAGIARISME.pdf Restricted to Repository staff only Download (281kB) |
|
Text
ARTIKEL KI.pdf Restricted to Repository staff only Download (550kB) |
Abstract
Lung cancer is a malignant disease in the lung, including primary malignancy and malignancy from outside the lung in the form of metastasis. Early lung cancer screening methods still have many weaknesses that can cause high incidence and mortality in lung cancer today, so an effective early detection method is needed. DNA methylation examination using the SHOX2 biomarker is considered to have advantages over other biomarkers. The study aims to determine the diagnostic accuracy of SHOX2 biomarkers in detecting early lung cancer, including sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV). The research design was a systematic review with pooled data. The literature search was conducted on five different journal databases using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) 2020 method covering articles from 2012-2022. Eighteen studies met the inclusion criteria. The results showed that the SHOX2 biomarker had a sensitivity value of 81.84% (95% CI, 78.91-84.52%), a specificity value of 82.38% (95% CI, 79.72-84.83%), a PPV value of 79.85% (95% CI, 77.40-82.09%) and an NPV value of 84.17% (95% CI, 82.01-86.12%). Based on its diagnostic accuracy, SHOX2 biomarker is not recommended as a primary diagnostic tool, but it can support the diagnosis after examination using Low Dose CT Scan (LDCT) to reduce the false positive rate.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Additional Information: | [No. Panggil: 1910211145] [Pembimbing 1: Yanto Sandy Tjang] [Pembimbing 2: Aulia Chairani] [Penguji: Andri Pramesyanti Pramono] |
| Uncontrolled Keywords: | early detection, lung cancer, SHOX2, diagnostic accuracy |
| Subjects: | R Medicine > RC Internal medicine R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
| Divisions: | Fakultas Kedokteran > Program Studi Kedokteran (S1) |
| Depositing User: | Solihat Nur Alifia |
| Date Deposited: | 02 Mar 2023 07:34 |
| Last Modified: | 02 Mar 2023 07:34 |
| URI: | http://repository.upnvj.ac.id/id/eprint/22590 |
Actions (login required)
 |
View Item |